Scaling Artificial Intelligence in Health
The OECD released a report outlining a policy checklist to scale artificial intelligence responsibly in health systems. It identifies four pillars—enablers, guardrails, meaningful engagement, and trustworthy deployment—covering nine policy categories and 43 guiding questions. The document highlights persistent barriers such as fragmented data, regulatory uncertainty, and workforce gaps. Member countries are using the checklist to shape national AI‑health strategies and promote cross‑border policy coherence.
60 Minutes Returns to Remote Area Medical
60 Minutes revisited Remote Area Medical (RAM), showing its expansion from 12 to 90 clinics and over one million patients served. The segment highlighted patients traveling hundreds of miles, sleeping in cars, and waiting in sub‑zero temperatures for basic dental...
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Glaukos Corporation will present a slate of scientific abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) meeting in Washington, D.C., and will exhibit at booth #407. The company is also sponsoring an educational symposium on Epioxa™,...
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
Bausch + Lomb announced it will present 45 scientific papers and posters at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, D.C., from April 9‑13, 2026. The sessions will feature data on its ELIOS minimally‑invasive...
From Noncovalent Fragment to (Non)covalent Leads Against PLPro
Researchers at Vanderbilt have leveraged a protein‑observed NMR fragment screen to revive interest in SARS‑CoV‑2 papain‑like protease (PLPro), an essential viral enzyme with few existing inhibitors. From 13,824 fragments, 77 hits were confirmed, leading to a non‑covalent series that progressed...
Quemliclustat
Quemliclustat (AB680) is a highly potent (5 pM) selective CD73 inhibitor that completed a Phase I trial in healthy volunteers, demonstrating a pharmacokinetic profile suitable for biweekly intravenous dosing. Early clinical data showed promising activity, prompting a successful Phase II study in pancreatic...
Pharma’s Silent Operational Killer: Lifecycle Change Management
Pharmaceutical companies face a hidden operational crisis: managing thousands of post‑approval changes across hundreds of markets using outdated, spreadsheet‑based processes. A typical large firm evaluates about 6,000 changes annually, generating roughly 90,000 country‑level regulatory filings that can take three to...
How a Hidden Genetic Mutation Creates a Severe Pediatric Anesthesia Risk
A rare mitochondrial DNA point mutation (mtND4 m.11232T>C) has been linked to catastrophic neurologic injury in children exposed to the volatile anesthetic sevoflurane. The mutation, maternally inherited and prevalent among people of Venezuelan ancestry, was identified after decades of isolated...
The Dangerous Trap of “One-Drug Cancer Cures”
Recent commentary warns against the allure of one‑drug cancer cures, arguing that such reductionist approaches echo past failures in oncology. While repurposed agents like ivermectin and fenbendazole demonstrate laboratory activity, the author cites severe side effects, including a patient death,...
MedTech Innovator Radar Forum April 7-9 Levels Up MedTech Industry’s Most Rigorous Evaluation Platform and Leading Accelerator Program
MedTech Innovator is debuting the Radar Forum, a single, invite‑only event held April 7‑9, 2026 in Manhattan Beach that replaces its previous multi‑city road‑tour pitches. The three‑day forum will host roughly 500 attendees, including 300 top experts who will evaluate the top...
In OMB’s FY 2027 Proposed Budget, Healthcare Is the Big Loser
The White House Office of Management and Budget’s FY 2027 budget proposal slashes health‑care spending, cutting the Department of Health and Human Services by $15 billion (12% less than FY 2026) and proposing a $911 billion reduction in Medicaid over ten years. At the...
Lawyer Rick Jaffe Is Doing What the Government Won’t Do; Challenge an Insane Court Ruling on Vaccine Policy
On April 4, 2026, attorney Rick Jaffe filed a massive 903‑page appeal challenging Judge Brian Murphy’s injunction that freezes all CDC childhood vaccine schedule changes. The judge ruled that only the agency’s advisory committee could originate policy, effectively paralyzing the CDC’s...
A Review Focused on Exerkines in Extracellular Vesicles Generated by Muscle Tissue
A new review examines how muscle‑derived extracellular vesicles (EVs) act as carriers of exercise‑induced exerkines, linking physical activity to systemic health benefits. It details the molecular cargo—proteins, lipids, and non‑coding RNAs—that modulates muscle stem‑cell activation, combats sarcopenia, and influences distant...
Unfinished Business in Diagnosing Clinical Obesity
The Lancet Commission introduced a new framework for diagnosing clinical obesity that emphasizes causal links between excess adiposity and disease. The Endocrine Society’s recent guidance pauses full endorsement, citing practical and equity concerns, especially the Commission’s exclusion of type 2...
Bringing the Bayesian Method to Clinical Trials: Q&A with Dr. Stacy Lindborg
The FDA issued a January 2026 draft guidance formally recognizing Bayesian methods for drug and biologic trials, offering sponsors a clear regulatory pathway to incorporate prior data and adaptive designs. Imunon CEO Dr. Stacy Lindborg explains how the guidance could...
Ketanji Brown Jackson Remains “Puzzled” By Medical Freedom
Justice Ketanji Brown Jackson filed the sole dissent when the Supreme Court struck down Colorado’s ban on conversion‑therapy, ruling the prohibition violated the First Amendment. The majority held that the state could not silence therapists for discussing viewpoints the law deemed disfavored....
Shining a Blue Light on an Overlooked Posttranslational Modification
Rice University chemist Zachary Ball unveiled a photochemical technique that selectively tags the often‑overlooked post‑translational modification pyroglutamate. By irradiating a protein mixture with 350‑400 nm blue light, a nickel‑based catalyst binds to the pyroglutamate ring and attaches a reporter tag. The method...
#386 – Aging Clocks—What They Measure, How They Work, and Their Clinical and Real-World Relevance
Aging clocks, built on DNA‑methylation patterns, aim to quantify biological age as a shortcut for long‑term health outcomes. Researchers view them as surrogate endpoints that could compress 20‑year anti‑aging trials into months, helping evaluate drugs or lifestyle interventions. However, the...
Viewpoint — ‘Miracle’ Peptides: Regulatory Greyzone and RFK, Jr. Propaganda Opens the U.S. to a Perilous Biohacking Experiment
Robert F. Kennedy Jr. announced on Joe Rogan’s podcast that the FDA plans to move roughly 14 experimental peptide compounds from a restricted status to availability through compounding pharmacies. While over 100 peptide drugs are FDA‑approved, the compounds marketed by...
LA’s 5 Best Psychiatric Clinics for Teen Mental Health Support
A 2026 guide ranks Los Angeles’ five top psychiatric clinics serving teens, covering telehealth, private outpatient, nonprofit, and full‑service models. The list includes Reimagine Psychiatry’s rapid three‑day virtual evaluations with pharmacogenetic testing, My LA Therapy’s therapist‑matching guarantee, the low‑cost nonprofit...
Confronting the Reality of Bullying in Medicine Today
Physician Dr. Muhamad Aly Rifai exposes the pervasive bullying culture in U.S. medicine, recounting a dermatology resident’s ordeal and his own legal battle after being fired for refusing unethical requests. He cites the AMA’s definition of workplace bullying and links...
The Peptide Economy vs the Healthcare AI Economy: Which Side of the Trade Matters More
The essay contrasts the rapidly expanding peptide economy—led by GLP‑1 and next‑generation obesity drugs—with the burgeoning healthcare‑AI sector, arguing they are interdependent rather than competing. Peptide revenues are projected to surpass $200 billion annually by 2030, while AI revenues sit at...
Living with Numbness After Mastectomy: The Unseen Impact on Survivorship
A recent patient survey shows that 87% of breast cancer survivors report persistent numbness after mastectomy, and one in four have suffered injuries because of the sensory loss. The numbness also diminishes body ownership, affecting intimacy, daily tasks, and emotional...
FDA Commissioner Marty Makary Is Operating in a Moral Vacuum; His Own Vacuum
Marty Makary, the FDA commissioner, cited a 2016 BMJ study claiming 250,000 U.S. deaths each year stem from medical error. The author of the blog post disputes that figure, noting that FDA‑approved drugs alone cause about 100,000 deaths annually and...
The Physician-in-Triage Model and Rapid Evaluation in Emergency Medicine
The physician‑in‑triage model shifts initial patient assessment from a permanent treatment room to a dedicated rapid‑evaluation area, allowing clinicians to take histories, perform exams, and order diagnostics immediately. By decoupling evaluation from bed availability, emergency departments can start the diagnostic...
Weekly Reads: 1st FDA-Approved CIRM Supported Therapy, Asymmetric Histone Inheritance, Stem Cell Retraction
The FDA has granted approval to KRESLADI, a gene‑editing therapy from Rocket Pharmaceuticals that treats severe leukocyte adhesion deficiency‑I (LAD‑I) in children without a matching bone‑marrow donor. This marks the first FDA‑approved product directly funded by California’s Institute for Regenerative...
Dr. Vinay Prasad Said He Would Deliver New COVID Vaccine RCTs. He Failed and Should STFU.
Pfizer and BioNTech announced they are halting a U.S. phase‑III trial of their updated COVID‑19 vaccine aimed at adults 50‑64 because enrollment fell far short of the planned 25,000‑30,000 participants. The companies said the decision was unrelated to safety or...
An Open Opportunity for My Critics to Deplatform Me on X
The author of a Substack post has issued a public challenge, offering to deplatform himself on X for the equivalent of 10 million follower‑days if he loses a debate on the COVID‑19 vaccine’s benefit. The wager expires on April 15, 2026, and the...
BREAKING: UK "Experts" Warn New Cicada CONVID Variant Could Target Children
UK health experts have flagged a new COVID‑19 sub‑variant, BA.3.2 nicknamed “Cicada,” as a potential dominant strain in the United Kingdom. The variant, now identified in 23 countries, carries roughly 75 spike‑protein mutations that could reduce the protective effect of...
Why Bariatric Patients Struggle with Protein and How to Fix It
Bariatric patients frequently fall short of protein recommendations, with up to 64% not meeting the minimum 60‑100 g daily intake. This shortfall leads to significant muscle loss—up to 25% of pre‑operative lean mass in the first year—and associated complications such as...
The Hospice Industries Fraud Crisis Just Got a Reckoning: Reading the FY 2027 CMS Proposed Rule Against the Backdrop of...
CMS released a FY 2027 hospice wage index and payment rate update proposing a 2.4% increase that would add roughly $785 million in Medicare payments. The rule arrives days after the Operation Never Say Die arrests, which uncovered a $60 million fraud ring...
Why ABIM’s Use of Medicare Claims Data Violates Physician Autonomy
The American Board of Internal Medicine (ABIM) has linked internal‑medicine board exam scores to Medicare claims data in research studies without informing or obtaining consent from the physicians involved. By merging exam performance with National Provider Identifier and claims information,...
AI Tested to Support Battlefield Medical Decisions
UK Defence Science and Technology Laboratory and the US DARPA conducted AI‑enabled battlefield medical triage trials, testing whether AI can be aligned with individual medics' ethical preferences. Simulated mass‑casualty scenarios in October 2025 let participants evaluate AI decisions without knowing...
The Competitive Fiction of a “Best” Obesity Treatment
Novo Nordisk issued a press release claiming its Wegovy (semaglutide) tablets outperform the newly approved orforglipron (Foundayo) tablets, basing the claim on a simulated treatment comparison to be presented at the Obesity Medicine Association meeting. The article warns that such...
Fine Particle Air Pollution Linked to Higher Alzheimer's Risk in Large US Study
A new PLOS Medicine analysis of 27.8 million Medicare beneficiaries found that long‑term exposure to fine particulate matter (PM2.5) raises Alzheimer’s disease risk by about 8.5 % per incremental increase. The study shows the majority of the risk stems from direct brain...
Forget Minnesota - The Amount Of Fraud Uncovered In California Is Staggering
California’s pandemic‑era unemployment insurance (UI) program paid roughly $20 billion in fraudulent claims, while state auditors estimate the overall fraud rate at about 7.6‑7.9%, translating to more than $1 billion lost. Parallel investigations reveal Medi‑Cal schemes siphoning at least $178 million and an...
![Why Hospital Systems Fail to Notice the Human Behind the Bill [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/ea65fd1d-d282-4c46-a750-620a3c3bb42f.jpeg)
Why Hospital Systems Fail to Notice the Human Behind the Bill [PODCAST]
Patient advocate Eric Goldfarb recounts his 88‑year‑old father’s hospital stay, where a weekend discharge, fragmented handoffs, and a bogus pregnancy‑test charge exposed deep communication gaps. Despite multiple revenue‑integrity reviews, the charge remained approved, illustrating how scripted processes can override common...
RA/QA News Roll: Late March 2026
The late‑March FDA Group news roll highlights mounting political pressure on HHS officials after a POLITICO MAHA poll showed mixed support for President Trump’s health agenda, while the agency grapples with internal turnover that could impede reform. FDA leadership announced...
Can Facet Arthroplasty Outperform TLIF for Spondy?
A prospective, multicenter FDA IDE trial compared the Total Posterior Spine (TOPS) facet arthroplasty system with traditional transforaminal lumbar interbody fusion (TLIF) in 249 patients with single‑level grade I degenerative spondylolisthesis. At 24 months, TOPS achieved an 85% composite clinical success rate...
Spacelabs Healthcare Announces Agreement to Provide Its Rothman Index® to Hospitals and Health Systems Through DEPTH Health
Spacelabs Healthcare has signed an agreement with DEPTH Health to integrate its Rothman Index into DEPTH’s Real‑Time Advisor for Clinical Expert Routing (RACER) platform. The Rothman Index aggregates 26 clinical data points into a 200‑point risk score that updates continuously,...
Friday Subscriber Discussion - Prove It
The newsletter featured a subscriber‑driven discussion on practical steps doctors’ offices can take to demonstrate thoughtful patient care. Contributors highlighted tangible improvements such as clear signage, comfortable waiting rooms, transparent pricing, staff communication training, and digital check‑in tools. The dialogue...
How a Minor Dry Cough Amplifies Caregiver Burden in Home Health Care
A seemingly minor dry cough can dominate daily life for families providing home health care, interrupting sleep, meals, and conversations. Because the symptom often disappears in the clinical setting, physicians may underestimate its impact, leaving caregivers to manage endless adjustments...
How to Treat Sacroiliac Joint Pain Effectively Today
The sacroiliac (SI) joint is responsible for roughly 15‑30% of chronic low‑back pain and is frequently misdiagnosed. Physicians use a stepwise approach—patient history, a cluster of provocation tests, selective imaging, and a diagnostic injection—to pinpoint the joint with about 91%...
RFK Jr. Appointed a Saboteur to Run the CDC’s Vaccine Panel — And Didn’t Know It
Dr. Robert Malone, a co‑inventor of mRNA vaccine technology, quit the CDC’s Advisory Committee on Immunization Practices (ACIP) alleging internal sabotage. He claims that a person personally appointed by RFK Jr. to oversee ACIP operations acted as a mole, undermining Secretary...
Ottawa Takes Charge of Vaccine Injury Compensation Program
The Canadian government has assumed direct control of the Vaccine Impact Assistance Program, moving it from the private consultancy OXARO to the Public Health Agency of Canada. The program, a no‑fault scheme, compensates individuals with serious, permanent injuries linked to...
The Riskiest Way to Prove You’re Right
For decades the medical establishment blamed stress for stomach ulcers, dismissing any bacterial cause. Dr. Barry Marshall, alongside pathologist Robin Warren, identified Helicobacter pylori as the culprit but faced widespread skepticism. To force acceptance, Marshall deliberately ingested a culture of...
Height or Weight, Which Is a Bigger PJK Risk Factor? (Not a Trick Question)
A multicenter retrospective review of 904 adult spinal deformity patients found that height, not weight, independently predicts proximal junctional kyphosis (PJK) after surgery. The risk rises with stature, peaking near 179 cm, and then plateaus. Weight and the height‑weight interaction showed...
Leucovorin for Autism: Why Physicians Must Protect Hope From Hype
Physicians warn that leucovorin, a folate derivative, is being hyped as an autism cure after political endorsements, despite lacking robust clinical evidence. Small studies suggest modest language gains, but no large randomized trials have confirmed efficacy and reported side effects...
Soquelitinib
Corvus Pharmaceuticals announced soquelitinib (CPI‑818), an oral covalent inhibitor that irreversibly engages ITK at Cys442 while sparing the related kinase RLK. The selectivity addresses the broader off‑target activity seen with earlier covalent ITK agents such as ibrutinib. Soquelitinib is currently...
This Is Ascent Health Services – the Secretive Swiss Company at the Heart of the Express Scripts Scandal
Ascent Health Services, a Swiss‑registered group purchasing organization created by Cigna’s Express Scripts in 2019, channels billions of dollars in manufacturer‑paid fees that should be passed through as rebates. The GPO’s offshore structure lets Cigna and its partners keep these...